Connecticut adds five medical cannabis conditions, will consider chronic pain

What’s the right revenue per square foot? What’s a realistic business outlook for cultivators? Get realistic market forecasts, state-by-state insights and benchmarks. Get the 2023 Factbook.

Medical marijuana companies in Connecticut likely will see a boost in business after the state expands its MMJ program with five new qualifying conditions.

A board of physicians recommended the new conditions at the Department of Consumer Protection’s regular meeting Monday, and the agency’s commissioner promptly accepted them, according to the Hartford Business Journal.

The new conditions are:

  • Interstitial cystitis, a chronic bladder pain syndrome.
  • Intractable neuropathic pain that is unresponsive to standard medical treatments.
  • Medial arcuate ligament syndrome, which causes severe abdominal pain.
  • Tourette syndrome.
  • Vulvodynia and vulvar burning.

The conditions still must be approved by the state Legislature’s Regulations Review Committee, the Business Journal reported.

When that approval is granted, Connecticut’s nine dispensaries will be able to sell medical marijuana for 36 conditions for adults and 10 for patients younger than 18.

Chronic pain, a major qualifying condition in many state medical marijuana programs, will be discussed at a future physician board meeting, according to the Business Journal.